Impact of pharmaceuticals discharges on the receiving environment: a two years monitoring results

Similar documents
Occurrence of Pharmaceuticals, Hormones, and Organic Wastewater Compounds in Pennsylvania Waters

Environmental Side Effects of Medication. Alistair B A Boxall Environment Department

Are Veterinary Medicines Causing Environmental Risks?

Occurrence of Antibiotics in Drinking Water

Journal of Environment and Earth Science ISSN (Paper) ISSN (Online) Vol.7, No.2, 2017

Water quality in Lake Kasumigaura

Middlesex University Research Repository

Pharmaceutical Compounds, Antibiotics, Hormones, and Wastewater Compounds in Pennsylvania Waters

Pharmaceutically Active Compounds in. Residential and Hospital Effluent, Municipal. Wastewater, and the Rio Grande. in Albuquerque, New Mexico

II CONVEGNO REGIONALE ISDE FVG. Udine, 28 novembre 2009 Ecovigilanza nella prevenzione delle malattie attraverso la tutela dell ambiente

What s new in EUCAST methods?

From Wastewater to Your Tap Water: The Vicious Cycle of Antibiotic Resistance

Mira Čelić1, Meritxell Gros1, Marinella Farre2, Damia Barceló1,2, Mira Petrović1,3

Quantification of EPA 1694 Pharmaceuticals and Personal Care Products in Water at the ng/l Level Utilizing Online Sample Preparation with LC-MS/MS

COS List. Page 1. trading & distribution excellence since Product CEP no. CoS status Country. Acamprosate OBTAINED Korea

Pharmaceuticals and personal care products in (PPCPs) in contaminated Red Sea seawater samples

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

Environmental impacts of Veterinary Medicines - State of knowledge, options for improvement

EUCAST recommended strains for internal quality control

Antibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi

QUALITY HEALTH CARE YOUR PREFERRED PARTNER IN. For better health

EU Water Framework Directive Precautionary Principle

YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.

CO-ACTION. Prof.dr. J.W. Mouton. Note : some technical and all results slides were removed. JPIAMR JWM Paris JWM Paris 2017

Routine internal quality control as recommended by EUCAST Version 3.1, valid from

YOUR COMPLETE SOURCE FOR MEDICAL MISSIONS SUPPLIES.

Rate In Rs.Ps (ED Included. Tax Extra) Sl No Name Of The Product Pack. Scheduled And Non-Scheduled Formulations Capsules

Methods development to detect antibiotic activity in water samples

Selection of antibiotic resistance in the environment

Environmentally persistent pharmaceutical pollutants; effects on living organisms

European Committee on Antimicrobial Susceptibility Testing

ESCMID Online Lecture Library. by author

Ultra-Fast Analysis of Contaminant Residue from Propolis by LC/MS/MS Using SPE

Key Lecture: Entry, occurrence, behavior and effects of pharmaceuticals in the environment

EurEau s Contribution to the European Commission s Strategic Approach on Veterinary Pharmaceuticals in the Environment

Streptococcus pneumoniae. Oxacillin 1 µg as screen for beta-lactam resistance

COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS

European Committee on Antimicrobial Susceptibility Testing

DSM Sinochem Pharmaceuticals From Gist to Sustainable Antibiotics

OUR BAY AND RIVERS ON DRUGS pharmaceuticals and illicit drugs as agents of ecological change

Fate and Transport of Hormones & Antimicrobials

Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut

Potential Impacts of Antibiotics in the Environment

AHFA 2016 Regulatory Summit. Antimicrobial Material Preservatives & Sustainability Considerations

Environmental Risk Assessment Summary Trimethoprim

Development of Analytical Methods for the Determination of Flunixin and Phenylbutazone Drug Residues in Edible Bovine Tissues

Combating Antimicrobial Resistance: A Manufacturing Perspective

Effect of EM on Growth, Egg Production and Waste Characteristics of Japanese Quail Abstract Introduction Experimental Procedures

AMR Industry Alliance Antibiotic Discharge Targets

Pharm 262: Antibiotics. 1 Pharmaceutical Microbiology II DR. C. AGYARE

Help with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST

AMOXICILLIN AND CLAVULANIC ACID TABLETS Draft proposal for The International Pharmacopoeia (February 2018)

Vibrio vulnificus. Vibrio vulnificus V. vulnificus. pectinata japonica)

The Institutional Animal Care and Use Committee (IACUC) Aquatic Animals: Analgesia and Anesthesia formulary

Annex 1. Description of data collection and analytical methods

Common Antibiotics in Wastewater of Sina and Besat Hospitals, Hamadan, Iran

Fecal coliforms and antibiotic resistance of Tuckahoe Creek

SIMAGCHEM CORPORATION

AMR dissemination in the environment Professor Liz Wellington

ACTA VET. BRNO 2013, 82: ; doi: /avb

An#bio#cs and challenges in the wake of superbugs

Global spread - Antibiotic resistance a critical sustainability question 2/14/2018. Managing resistance is in everyones interest

SUMMARY OF PRODUCT CHARACTERISTICS

Mixtures of veterinary medicinal compounds in manured soils

Factors influencing antibiotic resistance burden in municipal wastewater treatment plants

Chemical Residue Testing and the Role of Proficiency Testing Material at the Centre for Veterinary Drug Residues

Catalogue. August 2014 PRODUCT GUIDE

Einheit für pädiatrische Infektiologie Antibiotics - what, why, when and how?

Project Summary. Impact of Feeding Neomycin on the Emergence of Antibiotic Resistance in E. coli O157:H7 and Commensal Organisms

Mechanisms and Pathways of AMR in the environment

SAMPLE. Certificate in Understanding the Safe Handling of Medication in Health and Social Care PRESCRIPTION. Workbook 1 LEGISLATION.

Antibiotic. Antibiotic Classes, Spectrum of Activity & Antibiotic Reporting

Index. Note: Page numbers of article titles are in boldface type.

Amoxicillin trihydrate and potassium clavulanate. Amoxicillin trihydrate and potassium clavulanate. Amoxicillin trihydrate and potassium clavulanate

Emissions of NH 3 and greenhouse gases from pig houses: Influencing factors and mitigation techniques

Multi-residue Method II for Veterinary Drugs by HPLC (Animal and Fishery Products)

Staphylococcus aureus β. r r

in wastewater treatment plant

Strength Animal species Recommended dose. Member State Applicant Invented name Pharmaceutical form

ETX0282, a Novel Oral Agent Against Multidrug-Resistant Enterobacteriaceae

Antibiotics Removal in Biological Sewage Treatment Plants

Influence of Experimentally- induced clinical mastitis on Reproductive Performance of Dairy Cattle

Monitoring of Antibiotic Residues in Milk Development of the New Biosensor System MCR 3 for Routine Practical Analyses

Compliance of manufacturers of AST materials and devices with EUCAST guidelines


Study population The target population for the model were hospitalised patients with cellulitis.

IMPORTANCE OF GLOBAL HARMONIZATION OF ANTIMICROBIAL SUSCEPTIBILITY TESTING IN CANADA FOR DEFINING ANTIMICROBIAL RESISTANCE

Compliance of manufacturers of AST materials and devices with EUCAST guidelines

Trends en voorkomen van resistenties bij Salmonella, Campylobacter en E. coli geïsoleerd uit de voeding

Microbiology ( Bacteriology) sheet # 7

Microbiology : antimicrobial drugs. Sheet 11. Ali abualhija

Meloxicam vs etodolac cox 2 inhibition

Changing Practices to Reduce Antibiotic Resistance

Veterinary Chemistry Analyzers-Global Market Status and Trend Report

Antibiotics & Resistance

Urban Water Security Research Alliance

Successful stewardship in hospital settings

Antimicrobials & Resistance

Revolutionary Milk Analysis

Framework for monitoring antibiotic content and antibiotic resistance in the Danube Delta - the EnviroAMR project -

Transcription:

Impact of pharmaceuticals discharges on the receiving environment: a two years monitoring results www.isa-lyon.fr TRACES Group Technology and Research in Analytical Chemistry for Environment, health and their interactions Laure Wiest, Alexandre Bergé, Robert Baudot and Emmanuelle Vulliet 1

The SIPIBEL Site In 2012, opening of a new hospital : the Alps-Léman Hospital Center (CHAL) WW discharged into the Arve river www.sipibel.org Bellecombe WWTP 2

The SIPIBEL Site www.sipibel.org A field observatory Seven sampling sites 130 parameters Research actions Pollutant flows Treatment Risk Sociology 3

The SIPIBEL Observatory www.sipibel.org 450 beds 30,000 habitants 4

The SIPIBEL Observatory www.sipibel.org Physico-chemistry 5-day biochemical oxygen demand (BOD 5 ), chemical oxygen demand (COD), conductivity, dissolved organic carbon (DOC), ph, total suspended solids (TSS), total phosphorus (TP), phosphates (PO 4 3- ), kjedahl nitrogen (TKN), ammonium (NH 4+ ), adsorbable organic halogen (AOX) Emerging compounds Pharmaceuticals Microbiology Bacterial resistance to antibiotics Bioassays Microalgae, microcrustacean Endocrine disruptor Data base SIPIBEL 40,000 data 5

Pharmaceuticals Selection MOLECULE CONSOMME DOSABLE / EAU DOSABLE / CHAL ORGANISMES 1 17-β-ETHINYLESTRADIOL-EE2 1 4 ACIDE SALICYLIQUE 1 1 5 AMIODARONE 1 2 6 AMITRIPTYLINE 1 1 7 ATÉNOLOL 1 1 9 AZTREONAM 1 10 BÉZAFIBRATE 1 11 CARBAMAZEPINE 1 1 13 CIPROFLOXACINE 1 1 16 DESLORATADINE 1 2 17 DEXTROPROPOXYPHENE 3 18 DICLOFENAC 1 1 19 ECONAZOLE 1 1 25 HEXETIDINE 2 27 IBUPROFENE 1 1 34 ITRACONAZOLE 1 35 KETOPROFEN 1 1 36 LÉVONORGESTREL 1 1 38 MEROPENEME 1 1 43 MIFEPRISTONE 1 1 44 MITOTANE 1 2 45 NICARDIPINE 1 1 46 NORÉTHINDRONE 1 48 NORGESTIMATE 2 49 OXAZÉPAM 1 1 51 PARACETAMOL 1 1 53 PROPRANOLOL 1 1 55 RITONAVIR 1 1 56 ROXITHROMYCINE 1 1 57 SULFAMETHOXAZOLE 1 1 58 TAMOXIFENE 1 1 59 TELITHROMYCINE 1 2 62 VANCOMYCINE 1 1 - A list of 62 compounds - Hospital consumption - Domestic consumtion - PBT Index - A list of 35 compounds - Analytical feasibility - A list of 15 compounds - Economical feasibility 6

Pharmaceuticals List Analgesic Paracetamol Salicylic Acid Anti-inflammatory Ketoprofen Diclofenac Ibuprofen Beta-blocker Atenolol Propranolol Anti-fungal: Econazole Hormone: Ethinylestradiol Anti-convulsant: Carbamazepine Antibiotic Sulfamethoxazole Ciprofloxacin Aztreonam Meropenem Vancomycin

Analytical Method Sensitivity Wastewater 0.1 ng/l 1 ng/l 10 ng/l 100 ng/l 1 µg/l 10 µg/l 100 µg/l 1 mg/l 10 mg/l Surface water 0.1 ng/l 1 ng/l 10 ng/l 100 ng/l 1 µg/l 10 µg/l 100 µg/l 1 mg/l 10 mg/l 8

Raw wastewater Domestic vs Hospital

Domestic Wastewater 10

Hospital Wastewater 11

Raw WW: Concentrations 50 Concentrations (µg/l) 40 30 20 Domestic Hospital 10 0 Ketoprofen Ciprofloxacin Sulfamethoxazole Vancomycin 12

Raw WW: Flows /40 7 6 5 4 3 2 1 0 Flow (g/day) Domestic 4800 m 3 /d Ketoprofen Ciprofloxacin Sulfamethoxazole Vancomycin Hospital 130 m 3 /d Domestic Hospital 13

Raw WW: Variability 14

Raw WW: Metabolites Diclofenac (DCF) DCF COH DCF lactam DCF CH 2 OH CPAB Oxindole DCF 4 OH DCF 5 OH DCF carboxylic acid DCF glucuronide Sulfamethoxazole (SMX) SMX N-acetylated SMX glucuronide SMX iso 15

Raw WW: Metabolites Diclofenac (DCF) DCF COH DCF lactam DCF CH 2 OH CPAB Oxindole DCF 4 OH DCF 5 OH DCF carboxylic acid DCF glucuronide Sulfamethoxazole (SMX) SMX N-acetylated SMX glucuronide SMX iso 16

Raw WW: Metabolites Diclofenac (DCF) DCF COH DCF lactam DCF CH 2 OH CPAB Oxindole DCF 4 OH DCF 5 OH DCF carboxylic acid DCF glucuronide Sulfamethoxazole (SMX) SMX N-acetylated SMX glucuronide SMX iso 17

Wastewater treatment

Treated Wastewater 19

Treated WW: Flows 2,5 Flow (g/day) 2 1,5 1 0,5 0 Urbain Hôpital 20

Removal efficiency 120 Removal (%) 100 80 60 40 20 Domestic Hospital 0 21

Removal efficiency: variability Domestic WW Treatment 100,0 80,0 60,0 40,0 20,0 0,0 Diclofenac Ibuprofen Diclofenac 22

Removal efficiency: variability Hospital WW Treatment 100,0 80,0 60,0 40,0 20,0 0,0 Diclofenac Ibuprofen Diclofenac 23

Surface water

Arve Upstream Detection Frequency (%) Propranolol Ibuprofen Paracetamol < 30 % 30 à 70 % > 70 % Sulfamethoxazole Salicylic acid Econazole Ciprofloxacin Carbamazepine Ketoprofen Diclofenac Atenolol Not detected: * Ethinylestradiol * Hospital antibiotics 5 10 50 Concentration (ng/l) 25

Arve Downstream 26

Arve: a ressource for Human consumption Groundwater surface France-Switzerland border SIPIBEL Observatory 27

Arve: a ressource for Human consumption Groundwater surface France-Switzerland border SIPIBEL Observatory 28

Conclusions And Perspectives. 29

Conclusions Large scale of time and space consolidated data Raw and treated Wastewater, Surface water and groundwater Two years monitoring Hospital vs Domestic Wastewaters Hospital > Domestic in terms of concentrations Hospital < Domestic in terms of flows Mean removal efficiencies >50 % except Diclofenac and Carbamazepine Surface water and groundwater contamination in the ng/l range 30

Perspectives - Evolution of the list of Pharmaceuticals - Activated sludge analysis - Statistical correlation between parameters - Perspectives of the SIPIBEL observatory - Survey of Pharmaceuticals until at least 2018 - New projects? 31

Acknowledgments TRACES Group: Robert BAUDOT Alexandre BERGE Maëva FIEU Emmanuelle VULLIET www.isa-lyon.fr www.sipibel.org GRAIE: Vivien LECOMTE Elodie BRELOT 32

Thank you! 33